STADA Arzneimittel AG (OTCMKTS:STDAF) shares dropped 1.5% on Thursday . The company traded as low as $88.98 and last traded at $88.98, approximately 200 shares were traded during mid-day trading. The stock had previously closed at $90.37.
The stock has a 50 day moving average price of $90.37.
About STADA Arzneimittel (OTCMKTS:STDAF)
STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of pharmaceutical products for the health care and pharmaceutical markets worldwide. It operates in two segments, Generics and Branded Products. The Generics segment provides various generic active ingredients, including Tilidin Naloxon for pain; Atorvastatin for elevated cholesterol levels; Epoetin zeta for anemia; Diclofenac for pain/inflammation; and Omeprazol for gastric ulcer/reflux.
Recommended Story: The mechanics of the bid-ask spread in trading
Receive News & Ratings for STADA Arzneimittel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STADA Arzneimittel and related companies with MarketBeat.com's FREE daily email newsletter.